Professor of Surgical Oncology
General Surgery
Dr. Steven A. Curley, MD
|
|
Give Review
Doctor Steven A. Curley, MD works in the field of General Surgery. He researched medicine at University of Texas Medical School. He received 4 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". Steven A. Curley, MD is a published doctor as well. He has 101 publications published. The latest was: Generation of homogenous 3D pancreatic cancer cell spheroids using an improved hanging drop technique.
Publications
- Generation of homogenous 3D pancreatic Cancer cell spheroids using an improved hanging drop technique.
- Gold Nanoparticles Stabilized with MPEG-Grafted Poly(l-lysine): in Vitro and in Vivo Evaluation of a Potential Theranostic Agent.
- CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
- Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.
- Noninvasive radiofrequency treatment effect on mitochondria in pancreatic Cancer cells.
- Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma.
- Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
- Autophagy and enhanced chemosensitivity in experimental pancreatic Cancers induced by noninvasive radiofrequency field treatment.
- Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device.
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for ColoRectal Liver Metastases.
- IntraBiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome.
- Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients.
- Aspergillus fumigatus Hyphal Damage Caused by Noninvasive Radiofrequency Field-Induced Hyperthermia.
- Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma.
- Predictors of morbidity and mortality after hepatectomy in elderly patients: Analysis of 7621 NSQIP patients.
- Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: Analysis of 7621 NSQIP patients.
- Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate,...
- Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with...
- Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for ColoRectal Liver Metastases.
- Margin Status Remains an Important Determinant of Survival After Surgical Resection of ColoRectal Liver Metastases in the Era of Modern Chemotherapy.
- Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields.
- Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with ColoRectal Liver Metastases ...
- Association of diabetes and perineural invasion in pancreatic Cancer.
- Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic ColoRectal Metastases.
- Adjuvant Chemotherapy With FOLFOX for Primary ColoRectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepate...
- Greater Complexity of Liver Surgery is Not Associated with an Increased Incidence of Liver-Related Complications Except for Bile Leak: An Experience with 2,628 Consecu...
- Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy.
- Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis.
- Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: Analysis of 5651 National Surgical Quality Improvement Program patients.
- Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins.
- Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.
- Silencing thioredoxin induces liver Cancer cell senescence under hypoxia.
- Internalization of C60 fullerenes into Cancer cells with accumulation in the nucleus via the nuclear pore complex.
- APOBEC3G promotes liver metastasis in an orthotopic mouse model of coloRectal cancer and predicts human hepatic metastasis.
- Multiple kinase pathways involved in the different de novo sensitivity of pancreatic Cancer cell lines to 17-AAG.
- Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors.
- Improved survival after resection of liver and lung coloRectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic dis...
- Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and Pancreatic carcinoma xenografts.
- The ongoing history of thermal therapy for Cancer.
- Ablative procedures in surgical oncology. Preface.
- Is resection of coloRectal liver metastases after a second-line chemotherapy regimen justified?
- High survival rate after two-stage resection of advanced coloRectal liver metastases: response-based selection and complete resection define outcome.
- Case records of the Massachusetts General Hospital: Case 3-2011: a 58-year-old woman with a mass in the Liver.
- Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma.
- Radiofrequency ablation leads to excellent local tumor control and durable longterm survival in specific subsets of early stage HCC patients confirming to the Milan cr...
- Noninvasive radiofrequency field destruction of Pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
- Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for coloRectal liver me...
- Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model.
- Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.
- Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite inDuction of argininosuccinate synthetase-1.
- Radiofrequency field-induced thermal cytotoxicity in Cancer cells treated with fluorescent nanoparticles.
- Surgical strategies for synchronous coloRectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
- Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
- Effectiveness of positron emission tomography for predicting chemotherapy response in coloRectal cancer liver metastases.
- Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic Cancer cell lines.
- HCV-related hepatocellular carcinoma: From chronic inflammation to Cancer.
- Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
- Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: Analysis of 1,557 consecutive liver ...
- Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for coloRectal liver metastases.
- Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic Liver volumetry.
- Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
- Assessment tools in the training of surgical oncologists: educating trainees and educators.
- Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.
- NCCN clinical practice guidelines in oncology: hepatobiliary Cancers.
- The association of family history of liver Cancer with hepatocellular carcinoma: a case-control study in the United States.
- Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic coloRectal metastases.
- Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for coloRectal cancer liver metastases.
- Extrahepatic Bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival ...
- Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.
- Re: Right hepatic trisectionectomy for hepatoBiliary disease: results and an appraisal of its current role.
- Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of Liver function, portal vein embolization, and resec...
- Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human Cancer cells using cetuximab-targeted gold nanoparticles.
- Radiofrequency ablation versus resection for resectable coloRectal liver metastases: time for a randomized trial?
- Carbon nanotube-enhanced thermal destruction of Cancer cells in a noninvasive radiofrequency field.
- Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for coloRectal liver metastases.
- Systemic chemotherapy and two-stage hepatectomy for extensive bilateral coloRectal liver metastases: perioperative safety and survival.
- Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center Analysis.
- Pilot study of regional, hepatic intra-arterial paclitaxel in patients with Breast carcinoma metastatic to the liver.
- High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.
- Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.
- Comparison of CT methods for determining the fat content of the Liver.
- Resection of hepatic coloRectal metastases involving the caudate lobe: perioperative outcome and survival.
- Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence.
- Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in Pain, toxicities and survival?
- Results of a single-center experience with resection and ablation for sarcoma metastatic to the Liver.
- Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous Disease.
- Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.
- Solitary coloRectal liver metastasis: resection determines outcome.
- Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic coloRectal metastases.
- Accuracy of preoperative imaging of hepatic Tumors with helical computed tomography.
- Debunking dogma: surgery for four or more coloRectal liver metastases is justified.
- Outcome after curative resection for locally recurrent Rectal cancer.
- Comparison between hepatic wedge resection and anatomic resection for coloRectal liver metastases.
- Neoadjuvant chemotherapy for metastatic colon Cancer: a cautionary note.
- Outcomes after surgical treatment of coloRectal cancer liver metastases.
- One surgeon's unabashedly biased view on Liver resection.
- The role of focal Liver ablation in the treatment of unresectable primary and secondary malignant Liver tumors.
- Surgical resection after downsizing of coloRectal liver metastasis in the era of bevacizumab.
- Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Schools
University of Texas At Houston Medical School At Houston
University Nm
MD Anderson Canc Center
Procedures Preformed
- Appendectomy, Laparoscopic
- Biliary Drainage
- Biopsy of Breast
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of New Mexico -
University of Texas Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1942309075 | |
| NPPES Provider LastName | CURLEY | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 68.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942309075 |
| Last Name Of The Provider | CURLEY |
| First Name Of The Provider | STEVEN |
| View All |
